Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production (Q84072437)
Jump to navigation
Jump to search
scientific article published on 15 April 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production |
scientific article published on 15 April 2010 |
Statements
Olmesartan, a novel angiotensin II type 1 receptor antagonist, reduces severity of atherosclerosis in apolipoprotein E deficient mice associated with reducing superoxide production (English)
K Shimada
T Murayama
M Yokode
T Kita
M Fujita